Skip to main content
German Center for Infection Research
  • Research
    • Back
    • Bridging Topics
    • Research Areas
    • Infrastructures
    • Working Groups
    • Projects
    • African Partner Institutions
    • Clinical Trials
    • Publications
  • Translation
    • Back
    • Developing Medication
    • Successful Translation
    • Collaborations
    • German Centers for Health Research
  • DZIF Academy
  • Newsroom
    • Back
    • News
    • Media Centre
    • Press Office
    • Events
    • Jobs
  • About us
    • Back
    • Portrait
    • DZIF Structure and Bodies
    • Partner Sites
    • Executive Board
    • DZIF Patient Advisory Board
    • Staff
    • Main Office
    • Donations
  • De
  • |
  • En

Search

Breadcrumb

  1. Home
  2. Search
Aug 2022
mBio

A Variant Allele in Varicella-Zoster Virus Glycoprotein B Selected during Production of the Varicella Vaccine Contributes to Its Attenuation

Autoren
Sadaoka T et al.
Jul 2022
Clin Infect Dis

Longitudinal Immune Response to Three Doses of mRNA Vaccine Against COVID-19 in Pediatric Patients Receiving Chemotherapy for Cancer

Autoren
Lehrnbecher T et al.
Jul 2022
Clin Trials

A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats

Autoren
Longini IM et al.
Jul 2022
Emerg Infect Dis

Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant

Autoren
de Oliveira-Filho EF et al.
Jul 2022
EBioMedicine

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies

Autoren
Wilhelm A et al.
Jul 2022
Front Immunol

Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm's COVID-19 Vaccines

Autoren
Adjobimey T et al.
Prof Dirk Heinz, Prof Dirk Busch and Bettina Stark-Watzinger focus on a presentation

© DZIF

© DZIF
Oct 25 2022

Federal Research Minister learns about current infection research at the HZI and DZIF

As part of her autumn tour, the Federal Minister of Education and Research, Bettina Stark-Watzinger, visited the Helmholtz Centre for Infection Research (HZI) and the German Center for Infection

Heidelberg University Hospital

Genetically attenuated malaria parasites for immunization studies

While our understanding of the immune response to malaria improves, an efficient malaria vaccine remains elusive. We intend to use blood stage attenuated parasites which can be transmitted through mosquitoes as tools to dissect human responses to malaria parasites and as a novel vaccination strategy ...

Sep 16 2022

Prof. Oliver Cornely receives Johann Lucas Schönlein Plaque from the German-speaking Mycological Society

Prof. Oliver Cornely, infectiologist and coordinator of the DZIF Clinical Trial Unit at the University Hospital Cologne, has been awarded the Johann Lucas Schönlein Plaque by the German-speaking

Jun 2022
Travel Med Infect Dis

Factors impacting severe disease from chikungunya infection: Prioritizing chikungunya vaccine when available

Autoren
Grobusch MP
Connor BA

Pagination

Previous page ‹‹
Seite 14 Seite 15 Seite 16 Seite 17 Current page 18 Seite 19 Seite 20 Seite 21 Seite 22
Next page ››

Sitemap

  • Research
  • Translation
  • DZIF Academy
  • Newsroom
  • About us

At one click

  • Jobs
  • Media Centre
  • Press releases
  • Press contact
  • Glossary
  • Donations

Newsletter Subscription

Contact

Main Office of the DZIF e. V.
Inhoffenstraße 7
38124 Braunschweig
​

E-Mail Send mail

Fußbereichsmenü

  • DZIF Portal (internal)
  • Whistleblower system
  • Imprint
  • Privacy policy
  • Log in
  • Manage cookie consent
German Centers for Health Research
Supported by the Federal Ministry of Research, Technology and Space and the participating federal states